Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126694441 | 12669444 | 1 | I | 20160722 | 20160809 | 20160819 | 20160819 | EXP | US-SA-2016SA146970 | AVENTIS | 68.00 | YR | E | M | Y | 78.00000 | KG | 20160819 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126694441 | 12669444 | 1 | PS | LOVENOX | ENOXAPARIN SODIUM | 1 | Subcutaneous | UNKNOWN | 20164 | 80 | MG | SOLUTION FOR INJECTION | BID | ||||||
| 126694441 | 12669444 | 2 | SS | AXITINIB | AXITINIB | 1 | Oral | Y | UNKNOWN | 0 | 5 | MG | FILM-COATED TABLET | BID | |||||
| 126694441 | 12669444 | 3 | C | LIPITOR | ATORVASTATIN CALCIUM | 1 | Unknown | 0 | |||||||||||
| 126694441 | 12669444 | 4 | C | DULCOLAX NOS | BISACODYL OR DOCUSATE SODIUM | 1 | Unknown | 0 | SUPPOSITORY | ||||||||||
| 126694441 | 12669444 | 5 | C | TRANDATE | LABETALOL HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 126694441 | 12669444 | 6 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | |||||||||||
| 126694441 | 12669444 | 7 | C | HYZAAR | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Unknown | 0 | |||||||||||
| 126694441 | 12669444 | 8 | C | NORVASC | AMLODIPINE BESYLATE | 1 | Unknown | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126694441 | 12669444 | 1 | Pulmonary embolism |
| 126694441 | 12669444 | 2 | Renal cell carcinoma |
| 126694441 | 12669444 | 3 | Hyperlipidaemia |
| 126694441 | 12669444 | 4 | Constipation |
| 126694441 | 12669444 | 5 | Hypertension |
| 126694441 | 12669444 | 6 | Hypothyroidism |
| 126694441 | 12669444 | 7 | Hypertension |
| 126694441 | 12669444 | 8 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126694441 | 12669444 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126694441 | 12669444 | Amylase increased | |
| 126694441 | 12669444 | Anaemia | |
| 126694441 | 12669444 | Blood creatine phosphokinase increased | |
| 126694441 | 12669444 | Fall | |
| 126694441 | 12669444 | Haemoglobin decreased | |
| 126694441 | 12669444 | Haemorrhage | |
| 126694441 | 12669444 | Muscle haemorrhage | |
| 126694441 | 12669444 | Myalgia | |
| 126694441 | 12669444 | Peripheral swelling | |
| 126694441 | 12669444 | Presyncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126694441 | 12669444 | 1 | 20160527 | 0 | ||
| 126694441 | 12669444 | 2 | 20160414 | 20160705 | 0 | |
| 126694441 | 12669444 | 3 | 20140606 | 0 | ||
| 126694441 | 12669444 | 4 | 20160621 | 0 | ||
| 126694441 | 12669444 | 5 | 20160224 | 0 | ||
| 126694441 | 12669444 | 6 | 20160524 | 0 | ||
| 126694441 | 12669444 | 7 | 20150610 | 0 | ||
| 126694441 | 12669444 | 8 | 20160406 | 0 |